Initial Experience of Clinical Use of [^99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study

Numerous different molecules of prostate-specific membrane antigen (PSMA) ligands are used to detect prostate cancer (PCa); most approaches utilize gallium PET and a few reports describe the role of SPECT/CT. [^99mTc]Tc-PSMA-T4 is a new radiopharmaceutical designed for the diagnosis of pat...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jarosław B. Ćwikła, Marek Roslan, Iwona Skoneczna, Monika Kempińska-Wróbel, Michał Maurin, Wojciech Rogowski, Barbara Janota, Anna Szarowicz, Piotr Garnuszek
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2021-10-01
Schriftenreihe:	Pharmaceuticals
Schlagworte:	prostate cancer molecular imaging prostate specific membrane antigen (PSMA) [<sup>99m</sup>Tc]Tc-PSMA-T4
Online-Zugang:	https://www.mdpi.com/1424-8247/14/11/1107
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!